Old World cutaneous leishmaniasis: diagnosis and treatment

被引:71
作者
Masmoudi, Abderrahmen [1 ]
Hariz, Wala [1 ]
Marrekchi, Slaheddine [1 ]
Amouri, Mariem [1 ]
Turki, Hamida [1 ]
机构
[1] Hedi Chaker Hosp, Dept Dermatol, Sfax 3029, Tunisia
关键词
antimony; cutaneous leishmaniasis; diagnosis; Glucantime; leishmania; mucosal leishmaniasis; PCR; treatment;
D O I
10.3315/jdcr.2013.1135
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cutaneous leishmaniasis is a major world health problem. Diagnosis is suspected on evocative clinical presentation in patients living in or coming from endemic areas. Several methods have been used. The smear is a simple investigation used in endemic regions. The culture enables to identify the specimen. PCR has a high sensitivity. Montenegro's reaction is used in the epidemiological study. Pentavalent antimony derivatives remain the mainstay of systemic treatment. Their efficiency is well established. Their toxicity should be researched. Other treatments can be utilized, such as miltefosine. Local therapy is used in uncomplicated lesions. Injections of the pentavalent antimony derivate, cryotherapy and paromomycin ointmentsis are important options and should be used more frequently in Old World leishmaniasis.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 70 条
[1]   ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 REDUCES THE LOCAL PARASITE LOAD OF PATIENTS WITH DISSEMINATED CUTANEOUS LEISHMANIASIS [J].
AKUFFO, H ;
KAPLAN, G ;
KIESSLING, R ;
TEKLEMARIAM, S ;
DIETZ, M ;
MCELRATH, J ;
COHN, ZA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :775-780
[2]   CUTANEOUS LEISHMANIASIS IN KUWAIT - CLINICAL-EXPERIENCE WITH ITRACONAZOLE [J].
ALFOUZAN, AS ;
ALSALEH, QA ;
NAJEM, NM ;
ROSTOM, AI .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (07) :519-521
[3]  
Andrade-Narvaez Fernando J., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P191, DOI 10.1590/S0036-46652005000400003
[4]   Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis [J].
Asilian, A ;
Sharif, A ;
Faghihi, G ;
Enshaeieh, S ;
Shariati, F ;
Siadat, AH .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (10) :736-738
[5]   Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis [J].
Asilian, A ;
Sadeghinia, A ;
Faghihi, G ;
Momeni, A .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (04) :281-283
[6]   Human_Leishmaniasis@cytokines.bahia.br [J].
Barral-Netto, M ;
Brodskyn, C ;
Carvalho, EM ;
Barral, A .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (01) :149-155
[7]  
Beheshti M, 2007, SHIRAZ E MED J, V8, P4
[8]   FAILURE OF MEGLUMINE ANTIMONIATE TO CURE CUTANEOUS LESIONS DUE TO LEISHMANIA-MAJOR IN ALGERIA [J].
BELAZZOUG, S ;
NEAL, RA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1986, 80 (04) :670-671
[9]   FAILURE OF METRONIDAZOLE TREATMENT IN ETHIOPIAN MUCOCUTANEOUS LEISHMANIASIS [J].
BELEHU, A ;
NAAFS, B ;
TOUWLANGENDIJK, E .
BRITISH JOURNAL OF DERMATOLOGY, 1978, 99 (04) :421-422
[10]   Cutaneous leishmaniasis treatment by metronidazole: study of 30 cases [J].
Belhadjali, Hichem ;
Elhani, Ichrak ;
Youssef, Monia ;
Babba, Hammouda ;
Zili, Jameleddine .
PRESSE MEDICALE, 2009, 38 (02) :325-326